STOCKHOLDERS' EQUITY (Tables)

9 Months Ended

Sep. 30, 2022

STOCKHOLDERS' EQUITY

Schedule of transaction and other information relating to stock options

				Weighted-Average
				Remaining	Aggregate
	Number of	Weighted-Average		Contractual Term	Intrinsic
	Options	Exercise Price		(In Years)	Value
Outstanding at December 31, 2021	3,770,913	$	2.18	5.68	$	4,660,000
Grants	884,061	$	4.22	—		—
Exercised	(60,240)	$	0.83	—		—
Forfeited/cancelled/expired/settled	—	$	—	—		—
Balance as of September 30, 2022	4,594,734	$	2.59	5.98	$	7,701,000
Vested and expected to vest at September 30, 2022	4,541,393	$	2.57	5.93	$	7,700,000
Unvested at September 30, 2022	465,798	$	4.23	9.99	$	10,000
Exercisable at September 30, 2022	4,128,936	$	2.40	5.52	$	7,691,000

Schedule of transaction and other information relating to restricted stock grants

		Average
		Fair Value
		at Grant
	Shares	Date
Unvested at December 31, 2021	76,056	$	3.90
Grants	1,357,687	$	4.27
Vested	(999,479)	$	4.25
Forfeited/cancelled/expired	—	$	—
Unvested at September 30, 2022	434,264	$	4.27